Literature DB >> 17720153

Melatonin treatment improves the antioxidant status and decreases lipid content in brain and liver of rats.

Perumal Subramanian1, Shankaran Mirunalini, Seithikurippu R Pandi-Perumal, Ilya Trakht, D P Cardinali.   

Abstract

This study examines the effect of a daily administration of melatonin for 45 days at two doses (0.5 and 1.0 mg/kg body wt.) on antioxidant status, lipid peroxidation and lipid profile in the brain and liver in rats. Both doses of melatonin caused a significant decrease in lipid peroxidation and the levels of cholesterol, phospholipids, triglycerides and free fatty acids in the examined tissues. Concomitantly, the treatment with melatonin augmented the activity of the brain and liver antioxidant enzymes superoxide dismutase, catalase and glutathione peroxidase as well as increased glutathione levels. These results offer a support to the hypothesis that melatonin in pharmacological amounts effectively reduces oxidative stress and acts as an antihyperlipidemic agent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720153     DOI: 10.1016/j.ejphar.2007.06.011

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Comparison of the beneficial effect of melatonin on recovery after cut and crush sciatic nerve injury: a combined study using functional, electrophysiological, biochemical, and electron microscopic analyses.

Authors:  Yasemin Kaya; Levent Sarıkcıoğlu; Mutay Aslan; Ceren Kencebay; Necdet Demir; Narin Derin; Doychin N Angelov; Fatoş Belgin Yıldırım
Journal:  Childs Nerv Syst       Date:  2012-10-09       Impact factor: 1.475

3.  Vitamin D and melatonin protect the cell's viability and ameliorate the CCl4 induced cytotoxicity in HepG2 and Hep3B hepatoma cell lines.

Authors:  Dilşad Özerkan; Nesrin Özsoy; Erkan Yılmaz
Journal:  Cytotechnology       Date:  2014-07-06       Impact factor: 2.058

4.  Melatonin reduces ulcerative colitis-associated local and systemic damage in mice: investigation on possible mechanisms.

Authors:  P P Trivedi; G B Jena
Journal:  Dig Dis Sci       Date:  2013-08-23       Impact factor: 3.199

5.  Day and Night GSH and MDA Levels in Healthy Adults and Effects of Different Doses of Melatonin on These Parameters.

Authors:  Shilpa Chakravarty; Syed Ibrahim Rizvi
Journal:  Int J Cell Biol       Date:  2011-04-28

6.  Melatonin attenuates memory impairment induced by Klotho gene deficiency via interactive signaling between MT2 receptor, ERK, and Nrf2-related antioxidant potential.

Authors:  Eun-Joo Shin; Yoon Hee Chung; Hoang-Lan Thi Le; Ji Hoon Jeong; Duy-Khanh Dang; Yunsung Nam; Myung Bok Wie; Seung-Yeol Nah; Yo-Ichi Nabeshima; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-30       Impact factor: 5.176

Review 7.  Melatonin Therapy in Patients with Alzheimer's Disease.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Luis I Brusco
Journal:  Antioxidants (Basel)       Date:  2014-04-10

8.  Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells.

Authors:  S Carbajo-Pescador; C Steinmetz; A Kashyap; S Lorenz; J L Mauriz; M Heise; P R Galle; J González-Gallego; S Strand
Journal:  Br J Cancer       Date:  2012-12-20       Impact factor: 7.640

9.  Folic acid and melatonin ameliorate carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats.

Authors:  Hossam Ebaid; Samir Ae Bashandy; Ibrahim M Alhazza; Ahmed Rady; Sultan El-Shehry
Journal:  Nutr Metab (Lond)       Date:  2013-02-03       Impact factor: 4.169

10.  Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.

Authors:  G O'Neal-Moffitt; V Delic; P C Bradshaw; J Olcese
Journal:  Mol Neurodegener       Date:  2015-07-11       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.